Identification of semaphorin E as a non-MDR drug resistance gene of human cancers
AUTOR(ES)
Yamada, Tesshi
FONTE
The National Academy of Sciences of the USA
RESUMO
To improve cancer chemotherapy, a better understanding of the molecular mechanisms of drug resistance is essential. To identify the molecules responsible for drug resistance that is unrelated to MDR1 or MRP gene products, a eukaryotic expression cDNA library of cis-diamminedichloroplatinum(II) (CDDP)-resistant ovarian cancer TYKnuR cells was introduced into Cos-7 cells. After repeated CDDP selection, cDNA homologous to murine semaphorin E was isolated from surviving cells. Human semaphorin E (H-sema E) was overexpressed in CDDP-resistant cell lines and was readily induced not only by diverse chemotherapeutic drugs but also by x-ray and UV irradiation. Transfection of H-sema E conferred a drug-resistant phenotype to CDDP-sensitive cells. In addition, the aberrant expression of H-sema E protein was detected immunohistochemically in 14 of 42 (33.3%) recurrent squamous cell carcinomas removed at autopsy after extensive radiochemotherapy. Recently, another member of the semaphorin family, CD100, was shown to significantly improve the viability of B lymphocytes. These results suggest the involvement of semaphorins in diverse cell survival mechanisms.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=25101Documentos Relacionados
- Significance of MDR1 and multiple drug resistance in refractory human epileptic brain
- MDR1-Mediated Drug Resistance in Candida dubliniensis
- Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids
- Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
- A polymorphic HindIII site within the human multidrug resistance gene 1 (MDR1).